For Quick Alerts
For Daily Alerts

Aurobindo Pharma Falls Over 16% After USFDA Recalls VIA On Hyderabad Plant


On Monday, shares of Aurobindo Pharma fell over 16 percent to an intraday low of Rs 489.40 after the US FDA rescinded the 'Voluntary Action Indicated' (VAI) status on one of its plants on 21 February.

Aurobindo Pharma Falls Over 16% After USFDA Recalls VIA On Hyderabad Plant
Aurobindo Pharma: Quotes, News
BSE 403.60BSE Quote14.3 (3.54%)
NSE 403.45NSE Quote13.95 (3.46%)

The Food and Drug Administration's (FDA) decision to rescind the VAI on the company's Unit-IV in Hyderabad comes within 3 days of issuance.

Earlier, on 18 February, Aurobindo said that it had received the Establishment Inspection Report with VAI status, which enables a pharma company to undertake corrective action. Shares of the company rose over 21 percent on the following day with a spurt in trading volume of the stock.

Considering the sudden surge in share price last week, it is possible that short-term traders may have withdrawn their position on the stock on Monday, disappointed by the development, causing the equally sharp fall in value.

In a report, Kotak Securities said that the rescind of VAI status could mean that there is now a high risk of an official action indicated (OAI) for the unit.

The company's Unit-IV in Hyderabad is a key sterile facility as its is expected to account for $170 million or 10 percent of its estimated sales for the financial year 2019-20, and has the largest number of filings pending approval for the firm at 47 ANDAs (of total 153 pending ANDAs, of which 15 are expected to be launched in FY2021), the brokerage further noted.

Kotak Securities also lowered the stock's fair value back to Rs 540 per share from Rs 620.

Read more about: aurobindo pharma
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more